Glytech
GlyTech is a science-driven biotechnology company focusing on bringing glycans into practical therapeutic use.
Launch date
Employees
Market cap
-
Enterprise valuation
$9—14m (Dealroom.co estimates Apr 2013.)
Kyoto Kyoto Prefecture (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Spinout | ||
N/A | JPY296m | Series A | |
$5.8m | Series A | ||
$1.5m | Early VC | ||
$8.8m | Series A | ||
N/A | JPY482m | Late VC | |
$6.8m | Late VC | ||
Total Funding | $28.9m |
Recent News about Glytech
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.